Tenofovir alafenamide for treatment of HIV 1 in adults and adolescents

Document first published:
Page updated:
Topic:
Publication type:

NHS England will commission tenofovir alafenamide for the treatment of HIV-1 in adults, in accordance with the criteria outlined in this document.

Document

Tenofovir alafenamide for the treatment of HIV-1 in adults

Tenofovir alafenamide for the treatment of HIV-1 in adults

  • Microsoft Word
  • 90 KB

Summary

Version 2.

Published 19 August 2025.

Document

Tenofovir alafenamide for HIV infection: Engagement report

Tenofovir alafenamide for HIV infection: Engagement report

  • Microsoft Word
  • 68 KB

Document

Tenofovir alafenamide for HIV CPAG Summary Report

Tenofovir alafenamide for HIV CPAG Summary Report

  • Microsoft Word
  • 41 KB

Document

Tenofovir alafenamide for HIV clinical panel report

Tenofovir alafenamide for HIV clinical panel report

  • Microsoft Word
  • 51 KB

Document

Tenofovir alafenamide for HIV equality and health inequalities impact assessment

Tenofovir alafenamide for HIV equality and health inequalities impact assessment

  • Microsoft Word
  • 72 KB